This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.
will ensure that patients needing third-line treatment will continue to have access to CAR T-cell therapy. ... will mean that healthcare professionals in these centres will have this treatment as an important option for their patients.”.
With a total of 4bn being earmarked for actions addressing cancer, the plan is divided into four key areas: prevention, early detection, better access to treatment, and improved quality of life ... As part of the plan’s prevention goals, the EC is
rare genetic diseases and patients with cancer to benefit from earlier diagnosis and faster access to treatment. ... The potential for genomics to revolutionise the way we deliver healthcare is great – if we can detect treatable illnesses earlier and
high price medications’, offering hope and support to families who had otherwise not been able to access other available treatment options.
According to WHO’s website, of the 38 million people living with HIV, 5.9 million people who know they have HIV are not receiving treatment, while a further four million ... able to access this treatment worldwide in 2021.
Each day in 2021 around 850 children became infected with HIV and approximately 301 died from AIDS-related causes, mainly due to inadequate access to HIV care and treatment services, Gilead ... He continued: “Additional therapy choices help to ensure
More from news
Approximately 1 fully matching, plus 270 partially matching documents found.
An impressive achievement, but this is just base camp in the journey to conquer global issues of poor health, inequality in access to treatment, affordability and ensuring that scientific advances in ... Both technology and data will improve access to
In response to the need for continued access to treatment, pharma companies have offered aid through direct financial support, as well as the supply of life-saving medicines. ... With the help of WHO, Roche has shipped packs of antibiotics and batches of
specific devices, such screen readers, which may be used to access the PSP. ... Creating a direct avenue for advocacy, from both patient and HCP standpoints, drawing in key opinion leaders involved in enhancing knowledge and advocating for access to
For patients with rare diseases, where information is often scarce, being given access to trusted resources for disease education is so important. ... condition. Managing patients virtually using PSPs could potentially improve this by giving access to
Patients whose very survival depends on therapies that can only be delivered abroad must face a flurry of challenges to access the treatment that will hopefully change their lives forever. ... Furthermore, both pathways are impacted by several challenges
More from intelligence
Approximately 1 fully matching, plus 58 partially matching documents found.
Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
access to this crucial treatment to as many patients as possible.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
open up the conversation, encouraging women to demand better access to care and treatment, rather than suffer in silence. ... any barriers that need to be overcome, in order to help clients to tailor treatment in a meaningful way.
In the United Kingdom (UK), NHS waiting lists continue to grow, impacting patients’ access to timely diagnosis and treatment. ... As eye scans are currently examined by specialists, it can be a slow process and possibly preclude early treatment.
Further, market assessment tools, including online surveys, can reveal practice patterns and identify healthcare disparities and barriers to healthcare such as access to treatment. ... Clearly articulate clinical and economic value to build trust with
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. ... step. From the research and development stage all the way to patient access and
Trust is paramount because clinical trials are often for not-yet-proven treatments, but for some people taking part in a trial, it is their only option to access treatment not
More from PMHub
Approximately 0 fully matching, plus 41 partially matching documents found.
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...